Detalles de la búsqueda
1.
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials.
Cancer Sci
; 112(6): 2381-2392, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33686753
2.
Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3.
Oncologist
; 26(1): e53-e65, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955138
3.
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials.
Breast Cancer Res Treat
; 186(2): 417-428, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392835
4.
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
Breast Cancer Res Treat
; 184(1): 161-172, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789591
5.
6.
Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3.
Oncologist
; 26(3): e522, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33660385
7.
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups.
NPJ Breast Cancer
; 7(1): 80, 2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158513
8.
Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study.
Clin Cancer Res
; 14(11): 3477-86, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18519780
9.
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.
Clin Cancer Res
; 10(21): 7220-8, 2004 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15534095
Resultados
1 -
9
de 9
1
Próxima >
>>